Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • Mennään uimaan [undo]
  • Food laboratory [undo]
  • Συμπτώματα στο πρόσφατο παρελθόν [undo]
  • Verify patient identity and obtain e-consent before starting. [undo]
  • Furosemide (loop diuretic) [undo]
  • Digoxin (digitalis, positive inotropic drug) [undo]
  • Examination [undo]
  • go to espresso house [undo]
  • BEGIN SCENARIO [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21112
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway